OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 201, doi. 10.1093/jpids/piaa039
By:
- Krogstad, Paul;
- Samson, Pearl;
- Acosta, Edward P;
- Moye, Jack;
- Townley, Ellen;
- Bradford, Sarah;
- Brown, Emily;
- Denson, Kayla;
- Graham, Bobbie;
- Hovind, Laura;
- Sise, Thucuma;
- Teppler, Hedy;
- Mathiba, Sisinyana Ruth;
- Fairlie, Lee;
- Winckler, Jana L;
- Slade, Gretchen;
- Meyers, Tammy;
- Team, International Maternal Pediatric Adolescent AIDS Clinical Trials Network P1101
Publication type:
Article
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 2, p. 159, doi. 10.1093/jpids/piy139
By:
- Viani, Rolando M;
- Ruel, Theodore;
- Alvero, Carmelita;
- Fenton, Terry;
- Acosta, Edward P;
- Hazra, Rohan;
- Townley, Ellen;
- Palumbo, Paul;
- Buchanan, Ann M;
- Vavro, Cindy;
- Singh, Rajendra;
- Graham, Bobbie;
- Anthony, Patricia;
- George, Kathleen;
- Wiznia, Andrew;
- Team, The P1093 Study
Publication type:
Article
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2017, v. 6, n. 3, p. 294, doi. 10.1093/jpids/piw017
By:
- Cressey, Tim R.;
- Yogev, Ram;
- Wiznia, Andrew;
- Hazra, Rohan;
- Jean-Philippe, Patrick;
- Graham, Bobbie;
- Gonzalez, Amy;
- Britto, Paula;
- Carey, Vincent J.;
- Fletcher, Courtney V.;
- Acosta, Edward P.
Publication type:
Article
Pharmacokinetics of Once-Daily Darunavir/ Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2016, v. 5, n. 2, p. 131, doi. 10.1093/jpids/piu142
By:
- Larson, Kajal B.;
- Cressey, Tim R.;
- Yogev, Ram;
- Wiznia, Andrew;
- Hazra, Rohan;
- Jean-Philippe, Patrick;
- Graham, Bobbie;
- Gonzalez, Amy;
- Britto, Paula;
- Carey, Vincent J.;
- Acosta, Edward P.
Publication type:
Article
Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age.
Published in:
Journal of the Pediatric Infectious Diseases Society, 2015, v. 4, n. 4, p. e76, doi. 10.1093/jpids/piu146
By:
- Nachman, Sharon;
- Alvero, Carmelita;
- Acosta, Edward P.;
- Teppler, Hedy;
- Homony, Brenda;
- Graham, Bobbie;
- Fenton, Terence;
- Xia Xu;
- Rizk, Matthew L.;
- Spector, Stephen A.;
- Frenkel, Lisa M.;
- Worrell, Carol;
- Handelsman, Edward;
- Wiznia, Andrew
Publication type:
Article
Recombinant CD4-IgG2 in Human Immunodeficiency Virus Type 1-Infected Children: Phase 1/2 Study.
Published in:
Journal of Infectious Diseases, 2000, v. 182, n. 6, doi. 10.1086/317622
By:
- Shearer, William T.;
- Israel, Robert J.;
- Starr, Stuart;
- Fletcher, Courtney V.;
- Wara, Diane;
- Rathore, Mobeen;
- Church, Joseph;
- DeVille, Jaime;
- Fenton, Terence;
- Graham, Bobbie;
- Samson, Pearl;
- Staprans, Silvija;
- McNamara, James;
- Moye, John;
- Maddon, Paul J.;
- Olson, William C.
Publication type:
Article
Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years.
Published in:
Clinical Infectious Diseases, 2014, v. 58, n. 3, p. 413
By:
- Nachman, Sharon;
- Zheng, Nan;
- Acosta, Edward P.;
- Teppler, Hedy;
- Homony, Brenda;
- Graham, Bobbie;
- Fenton, Terence;
- Xu, Xia;
- Wenning, Larissa;
- Spector, Stephen A.;
- Frenkel, Lisa M.;
- Alvero, Carmelita;
- Worrell, Carol;
- Handelsman, Edward;
- Wiznia, Andrew
Publication type:
Article
Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age.
Published in:
Journal of Clinical Pharmacology, 2015, v. 55, n. 7, p. 748, doi. 10.1002/jcph.493
By:
- Rizk, Matthew L.;
- Du, Lihong;
- Bennetto‐Hood, Chantelle;
- Wenning, Larissa;
- Teppler, Hedy;
- Homony, Brenda;
- Graham, Bobbie;
- Fry, Carrie;
- Nachman, Sharon;
- Wiznia, Andrew;
- Worrell, Carol;
- Smith, Betsy;
- Acosta, Edward P.
Publication type:
Article
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Published in:
PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186589
By:
- Huang, Liusheng;
- Carey, Vincent;
- Lindsey, Jane C.;
- Marzan, Florence;
- Gingrich, David;
- Graham, Bobbie;
- Barlow-Mosha, Linda;
- Ssemambo, Phionah K.;
- Kamthunzi, Portia;
- Nachman, Sharon;
- Parikh, Sunil;
- Aweeka, Francesca T.;
- null, null
Publication type:
Article

Found: 9